Articles > Devices & Technology

  1. A Day without My CGM: I Couldn’t Do It

    I couldn’t do it. I couldn’t go a day—wait, let’s be real here—more than four hours without my continuous glucose monitor (CGM). Why? Okay, maybe because I’m nearly eight months pregnant and knowing each single number is critical to not only my health, but my child’s, but holy moly I’m addicted to that info. I even […]

    Read More
  1. Polyphotonix Offers An Innovative Vision for Treating Retinopathy

    Last fall, T1D Exchange held its 1st Annual Diabetes Innovation Challenge, an open competition seeking novel treatments for diabetes. The competition introduced our partners and collaborators from industry, academic research, other diabetes nonprofits, clinical partners and patient/caregiver community to over 60 groundbreaking diabetes therapies or technologies currently in development. One of these applicants, UK-based Polyphotonix, […]

    Read More
  2. Together We’re Fighting for the Next Generation of Innovators

    When the type 1 community comes together, we’re louder, stronger, and more powerful. T1D Exchange is a unique nonprofit that combines our collective voices to demand better treatments and better care. This week, we are highlighting the various ways in which our community has made a difference…Together One. We live in an amazing time of […]

    Read More
  3. Are You Not Getting a CGM Because Your Doctor Isn’t Prescribing It?

    Together We’re One: Fighting for Choice and Competition in the Marketplace When the type 1 community comes together, we’re louder, stronger, and more powerful. T1D Exchange is a unique nonprofit that combines our collective voices to demand better treatments and better care. This week, we are highlighting the various ways in which our community has […]

    Read More
  1. “Not Good Enough”: How One Dad Led the Change in Diabetes Devices through Grassroots Research and Collaboration

    jeffrey brewer bigfoot artificial pancreas

    For over 15 years, academic leaders in clinical research and engineering worked with funders, patient groups and industry to support the advancement of AID. In 2002, Bigfoot Biomedical CEO Jeffrey Brewer’s technology career was flourishing, having founded two successful startup dot-coms that later became publicly traded companies. He had just moved his family from Silicon […]

    Read More
  2. CMS Announces CGM Coverage for Medicare Patients; T1D Exchange Data Supported Decision

    The diabetes community is rejoicing over today’s announcement that the U.S. Centers for Medicare & Medicaid Services (CMS) have published new criteria for covering the Dexcom G5 Mobile CGM (continuous glucose monitoring) system for all people with diabetes on intensive insulin therapy. This decision comes after years of hard work, rigorous studies and advocacy by many […]

    Read More
  3. Paving the Road to Automated Insulin Delivery: The Important Role of Nonprofits

    Glu T1D Exchange diabetes insulin

    Over the past decade the type 1 diabetes community has been working together to develop and deliver new solutions that will improve outcomes with type 1 diabetes—while relieving the burden. When it comes to automated insulin delivery (AID), our community has invested a lot – hundreds of millions of dollars, years of research, innovation and […]

    Read More
  4. Your Questions Answered: The MiniMed 670G System

    In September, the FDA approved a big leap forward in diabetes technology, the world’s first hybrid closed loop system. The MiniMed® 670G system is designed for people with type 1 diabetes who are 14 and older.  Having been diagnosed with type 1 in 1989, when blood glucose meters were bigger than the current larger iPhone, […]

    Read More